Satish G Namjoshi, MD
Pediatrics · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Namjoshi’s office at (480) 609-8100 to ask if they take your plan before you enroll.
California Medical Board record
Licence C188131 · Current
Licensed to practise in California · since 2023 · expires 2027-07-31 · Osmania University, Kakatiya Medical College.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$5,343 in 2024
Medicaid paid $5,343 for 132 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 37 | $2,952 |
| Short return visit (20+ min) | 35 | $1,782 |
| Short return visit | 60 | $610 |
| 2024 | 132 | 3 | 23 | $5,343 |
| 2023 | 166 | 3 | 19 | $9,431 |
| 2022 | 195 | 3 | 23 | $12,887 |
| 2021 | 309 | 7 | 27 | $16,633 |
| 2020 | 274 | 6 | 23 | $10,873 |
| 2019 | 461 | 5 | 34 | $18,191 |
| 2018 | 489 | 6 | 29 | $20,258 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 73 | $3,890 |
| Return visit (30+ min) | 46 | $3,596 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 47 | $1,945 |
2022
| Return visit (30+ min) | 96 | $7,789 |
| Short return visit (20+ min) | 63 | $3,337 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 36 | $1,761 |
2021
| Return visit (30+ min) | 99 | $7,852 |
| Short return visit (20+ min) | 102 | $4,912 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose | 20 | $1,579 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 13 | $1,167 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 28 | $989 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 32 | $134 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use | 15 | $0 |
2020
| Return visit (30+ min) | 84 | $5,533 |
| Short return visit (20+ min) | 59 | $2,660 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 68 | $2,390 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $231 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 23 | $58 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 26 | $0 |
2019
| Short return visit (20+ min) | 277 | $12,469 |
| Return visit (30+ min) | 48 | $3,276 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 78 | $2,187 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 21 | $259 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 37 | $0 |
2018
| Return visit (30+ min) | 146 | $9,553 |
| Short return visit (20+ min) | 153 | $6,834 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 118 | $3,564 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $185 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 39 | $121 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 21 | $0 |
Money from drug and device companies
$74 in 2024
| 2024 | 2 | 4 | None | $74 |
| 2023 | 6 | 8 | None | $171 |
| 2022 | 7 | 11 | None | $208 |
| 2021 | 7 | 9 | None | $179 |
| 2020 | 5 | 5 | None | $86 |
| 2019 | 2 | 2 | None | $28 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Gardasil | $38 | 2 payments
|
| Pfizer | Trumenba | $37 | 2 payments
|
See all 4 published payments
| Pfizer | Meals · 2024-06-11 | Trumenba | $19 |
| Merck Sharp & Dohme | Meals · 2024-03-18 | Gardasil | $20 |
| Pfizer | Meals · 2024-02-29 | Trumenba | $17 |
| Merck Sharp & Dohme | Meals · 2024-02-13 | Gardasil | $18 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $171
| Pfizer | Prevnar 20 | $59 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Flumist Quadrivalent | $29 | 1 payment
|
| kaleo | Auvi-Q | $27 | 1 payment
|
| Sobi | Synagis | $21 | 1 payment
|
| Merck Sharp & Dohme | Rotateq | $18 | 1 payment
|
| Cranial Technologies | Doc Band | $17 | 1 payment
|
2022: $208
| Sanofi Pasteur | Menquadfi | $51 | 2 payments
|
| Sobi | Synagis | $47 | 2 payments
|
| GlaxoSmithKline | Bexsero | $36 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $29 | 2 payments
|
| Supernus Pharmaceuticals | Qelbree | $17 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $15 | 1 payment
|
| Cranial Technologies | Doc Band | $13 | 1 payment
|
2021: $179
| Supernus Pharmaceuticals | Qelbree | $42 | 2 payments
|
| Merck Sharp & Dohme | Gardasil 9 | $36 | 2 payments
|
| kaleo | Auvi-Q | $30 | 1 payment
|
| Sanofi Pasteur | Menquadfi | $24 | 1 payment
|
| Sobi | Synagis | $21 | 1 payment
|
| Cranial Technologies | Doc Band | $14 | 1 payment
|
| GlaxoSmithKline | Bexsero | $13 | 1 payment
|
2020: $86
| Ironshore Pharmaceuticals | Jornay Pm | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $17 | 1 payment
|
| Genentech USA | Xofluza | $16 | 1 payment
|
| Cranial Technologies | Doc Band | $15 | 1 payment
|
| AbbVie | None | $14 | 1 payment
|
2019: $28
| GlaxoSmithKline | Bexsero | $14 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm 20mg Capsules (Bottle of 100) | $13 | 1 payment
|
Professional record
- NPI
- 1245231422
- Licence
- CA 188131California C188131: Current · expires 2027-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2330 University Ave Unit 200, East Palo Alto, CA, 94303
- NPI first listed
- 2005-08-10
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-09
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.